BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8278691)

  • 1. Prorenin and the renin-angiotensin system in diabetic nephropathy.
    Hsueh WA; Anderson PW
    Semin Nephrol; 1993 Nov; 13(6):573-80. PubMed ID: 8278691
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes, nephropathy, and the renin system.
    Hollenberg NK
    J Hypertens Suppl; 2006 Mar; 24(1):S81-7. PubMed ID: 16601578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular maturation and atresia--possible role of intraovarian regulatory factors.
    Mukhopadhyay AK; Brunswig-Spickenheier B
    J Reprod Fertil Suppl; 1996; 50():105-12. PubMed ID: 8984172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic nephropathy and molecular biology of the renin-angiotensin system in the diabetic kidney].
    Rodríguez Pérez JC; Barrio Castellanos R
    Med Clin (Barc); 1995 Nov; 105(18):708-15. PubMed ID: 8538254
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiopathology of the renin-angiotensin system in the ovary.
    De Nuccio I; Salvati G; Genovesi G; Paolini P; Marcellini L; Schiavello V; Re M
    Minerva Endocrinol; 1999 Jun; 24(2):77-81. PubMed ID: 10941427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
    Jacobsen PK; Rossing P; Parving HH
    Nephrol Dial Transplant; 2006 Jul; 21(7):2030-1. PubMed ID: 16449277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution of methodological problems in prorenin measurement and investigations of tissue renin-angiotensin systems in the female reproductive tract.
    Hagemann A
    Dan Med Bull; 1997 Nov; 44(5):486-98. PubMed ID: 9408735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic vascular complications and circulating prorenin].
    Minagawa S; Ohmura E; Imai Y; Kawazu S
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():108-14. PubMed ID: 12430215
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular renin angiotensin: EM immunocytochemical localization of prorenin.
    Wallow IH; Sramek SJ; Bindley CD; Darjatmoko SR; Gange SJ
    Curr Eye Res; 1993 Oct; 12(10):945-50. PubMed ID: 8293670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy].
    Metsärinne K
    Duodecim; 2003; 119(24):2445-50. PubMed ID: 14870506
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL; Gleason BL
    Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.